Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02457962 · ClinicalTrials.gov registry record
Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
A clinical trial of Solid Tumors and Hematologic Malignancies, sponsored by Mayo Clinic.
- Active
- Registry status
- 14,266
- Enrollment target
- 1
- Study location
NCT02457962: Active study of Solid Tumors and Hematologic Malignancies, sponsored by Mayo Clinic.
NCT02457962 is a study of Solid Tumors and Hematologic Malignancies that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 14,266 participants, above the 170-participant average among 125 other Solid Tumors trials with a reported enrollment target (8292% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02457962, a study of Solid Tumors and Hematologic Malignancies, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 14,266 participants
- Enrollment target
- 1
- Study location
Study Summary
To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,266 participants |
| Start Date | 2015-04-23 |
| Est. Completion | 2026-04 |
What the registry record for NCT02457962 still lists
NCT02457962 is an observational study that tracks outcomes without assigning an intervention. Its 14,266 participants enrollment target places it among the larger protocols in the corpus, above the 170-participant average among 125 other Solid Tumors trials with a reported enrollment target (8292% higher).
The record links to 2 conditions, with Solid Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT02457962 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02457962 about?
NCT02457962 is a clinical study titled "Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study". To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.
What is the current status of trial NCT02457962?
This trial is currently active not recruiting. The enrollment target is 14,266 participants. The study started on 2015-04-23. Estimated completion is 2026-04.
What conditions does trial NCT02457962 study?
This clinical trial studies the following conditions: Solid Tumors, Hematologic Malignancies.
Who is sponsoring clinical trial NCT02457962?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02457962 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02457962's enrollment target sits among peer trials
14,266 1st of 125 higher than 125 of 125 other Solid Tumors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Solid Tumors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
RECRUITING · Phase 4
-
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of INCB123667 in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
-
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT05359016 · 14,600 participants · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT06849869 · 14,820 participants · NA
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI